NLGP mediated therapeutic tumor growth restriction is CD8+ T cell dependent.
In this CD8 dependent tumor growth restriction participation of CD4+ T cells is essential.
CD4+ T cell depletion increases CD8+ T cell frequency in tumor bearing mice, however, CD8+ T cell functions are seriously hampered.
CD4+ T cell depletion affects NLGP vaccine induced CD8α+ dendritic cell dependent signaling.
IL-2 and physical presence of CD4+ T cells are mutually required for optimum CD8+ T cell functions.